No CrossRef data available.
Article contents
Prevalence and Risk Factors of Hypothyroidism: Findings from the Canadian Study of Health and Aging*
Published online by Cambridge University Press: 29 November 2010
Abstract
The objective of this research is to determine the prevalence and risk factors for primary hypothyroidism in a sample of Canadian seniors. The Canadian Study of Health and Aging (CSHA) was a prevalence survey of seniors living at home and in long-term care facilities (n = 10,263). Detailed clinical examinations were conducted on 2,914 seniors, of which 1,415 had serum TSH levels measured.The ten Canadian Provinces were grouped into five geographic regions (Atlantic, Quebec, Ontario, Prairies and British Columbia). Only seniors who underwent detailed clinical examinations (n = 2,914) are included. Hypothyroidism was defined as seniors taking thyroid hormone replacement or seniors having a serum TSH level greater than 10 mU/L. An estimated 9.6 per cent of seniors had hypothyroidism, 5.1 per cent were inadequately treated and 2.1 per cent were untreated. Age, gender, cultural background, geographic region and place of residence were potential risk factors for hypothyroidism. Hypothyroidism was found to be a prevalent problem in this population.
Résumé
Cette recherche visait à déterminer la prévalence et les facteurs de risque de l'hypothyroïdie primaire, dans un échantillonnage d'aîné(e)s canadien(ne)s. L'Étude sur la santé et le vieillissement au Canada (ESVC) portait sur les aîné(e)s vivant à la maison et dans des établissements de soins de longue durée (n = 10,263). On a effectué un examen clinique de 2 014 aîné(e)s et on a mesuré les niveaux de TRH de 1415 d'entre eux. On a divisé les dix provinces canadiennes en cinq régions géographiques (Atlantique, Québec, Ontario, Prairies et Colombie-Britannique). On a retenu seulement ceux qui avaient subi un examen clinique (n = 2 914). Les aîné(e)s souffrant d'hypothyroïdie étaient ceux qui prenaient des hormone substitutives ou les aîné(e)s dont le degré de TRH était supérieur à 10 mU/L. On a estimé à 9,6 pour cent le nombre d'aîné(e)s souffrant d'hypothyroïdie; 5,1 pour cent n'étaient pas soignés de façon appropriée et 2,1 pour cent n'étaient pas du tout soignés. L'âge, le sexe, les antécédents culturels, l'origine géographique et le lieu de résidence constituaient des facteurs de risque de l'hypothyroïdie. On a conclu que l'hypothyroïdie est un problèms inherent à ce groupe.
Keywords
- Type
- Articles
- Information
- Canadian Journal on Aging / La Revue canadienne du vieillissement , Volume 20 , Issue 1 , Printemps/Spring 2001 , pp. 127 - 135
- Copyright
- Copyright © Canadian Association on Gerontology 2001
References
1.Tunbridge, WM, Evered, DC, Hall, R, Appleton, D, Brewis, M, Clark, F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7:481–93.CrossRefGoogle Scholar
2.Sawin, CT, Castelli, WP, Hershman, JM, McNamara, P, Bacharach, P. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985; 145:1386–8.Google Scholar
3.Lloyd, WH, Goldberg, IJL. Incidence of hypothyroidism in the elderly. BMJ 1961; 2:1256–9.CrossRefGoogle ScholarPubMed
4.Hennessey, JV, Evaul, JE, Tseng, YC, Burman, KD, Wartofshy, L. L-thyroxine dosage: a reevaluation of therapy with contempory preparations. Ann Inter Med 1986; 105:11–5.CrossRefGoogle Scholar
5.Ross, DS, Daniels, GH, Gouveia, D. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab 1990; 71:764–96.Google Scholar
7.Canadian Study of Health and Aging Working Group. Canadian Study of Health and Aging; study methods and prevalence of dementia. Can Med Assoc J 1994; 150:899–913.Google Scholar
8.Canadian Study of Health and Aging Working Group. The Canadian Study of Health and Aging; risk factors for Alzheimer's disease in Canada. Neurology 1994; 44:2073–80.Google Scholar
9.Canadian Study of Health and Aging Working Group. Patterns of caring for people with dementia in Canada. Can J Aging 1994;13(4):470–87.Google Scholar
10.Ostbye, T, Crosse, E. Net economic costs of dementia in Canada. Can Med Assoc J 1994; 151:1457–64.Google Scholar
12.Falkenberg, M, Kagedal, B, Norr, A. Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand 1983; 214:261.Google Scholar
13.Hintz, G, Burghardt, U, Baumert, J, Windeler, J, Kobberling, J. Prevalence of thyroid dysfunction in elderly subjects from the general population in an iodine deficiency area. Aging (Milano) 1991;Dec; 3(4):325–31.Google Scholar
14.Eden, S, Sundbeck, G, Lindstedt, G, Lundberg, PA, et al. Screening for thyroid disease in the elderly. Serum concentrations of thyrotropin and 3,5,3-triio-dothyronine in a representative population of 79-year-old women and men. Compr Gerontol [A] 1988:Feb;2(1):40–5.Google Scholar
15.Bagchi, N, Brown, TR, Parish, RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990: Apr;150(4):785–7.Google Scholar
16.Livingston, EH, Hershman, JM, Sawin, CT, Yoshikawa, TT. Prevalence of thyroid disorders and abnormal thyroid tests in older hospitalized and ambulatory persons. J Am Geriatr Soc 1987;35(2):109–14.Google Scholar
17.Tunbridge, WMG, Evered, D, Hall, R, et al. The spectrum of thyroid disease in a community: The Whickham survey. Clin Edocrinol (Oxf) 1977; 7:481.Google Scholar
18.Drinka, PJ, Nolten, WE. Prevalence of previously undiagnosed hypothyroidism in residents of a midwestern nursing home [published erratum appears in South Med J. 1991 June; 84(7):936], SouthMed J. 1990: Nov; 83(11):1259–61, 1265.Google Scholar